These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6250469)

  • 1. In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesis.
    Van den Bossche H; Willemsens G; Cools W; Cornelissen F; Lauwers WF; van Cutsem JM
    Antimicrob Agents Chemother; 1980 Jun; 17(6):922-8. PubMed ID: 6250469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ergosterol synthesis in Candida albicans by ketoconazole [proceedings].
    Van Den Bossche H; Willemsens G; Cools W; Cornelissen F
    Arch Int Physiol Biochim; 1979 Oct; 87(4):849-51. PubMed ID: 93943
    [No Abstract]   [Full Text] [Related]  

  • 3. The mechanism of action of the new antimycotic ketoconazole.
    Borgers M; Van den Bossche H; De Brabander M
    Am J Med; 1983 Jan; 74(1B):2-8. PubMed ID: 6295147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of inhibition of sterol synthesis with growth-inhibitory action of imidazole antimycotics in Candida albicans.
    Nicholas RO; Kerridge D
    J Antimicrob Chemother; 1989 Jan; 23(1):7-19. PubMed ID: 2663807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new era in antimycotic agents.
    Rippon JW
    Arch Dermatol; 1986 Apr; 122(4):399-402. PubMed ID: 3006601
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of ketoconazole on the fungicidal action of amphotericin B in Candida albicans.
    Sud IJ; Feingold DS
    Antimicrob Agents Chemother; 1983 Jan; 23(1):185-7. PubMed ID: 6299182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical mode of action and enantiomeric selectivity of SDZ 89-485, a new triazole antimycotic.
    Ryder NS
    J Med Vet Mycol; 1990; 28(5):385-94. PubMed ID: 2283585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activity of ketoconazole in clinical isolates of candida albicans cultured in a mycelium promoting medium.
    Van Cutsem J; Borgers M; De Brabander M
    Mykosen; 1981 Oct; 24(10):596-602. PubMed ID: 6270550
    [No Abstract]   [Full Text] [Related]  

  • 9. Specific inhibition of fungal sterol biosynthesis by SF 86-327, a new allylamine antimycotic agent.
    Ryder NS
    Antimicrob Agents Chemother; 1985 Feb; 27(2):252-6. PubMed ID: 4039119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of sterol 14 alpha-demethylation of Candida albicans with NND-502, a novel optically active imidazole antimycotic agent.
    Niwano Y; Koga H; Kodama H; Kanai K; Miyazaki T; Yamaguchi H
    Med Mycol; 1999 Oct; 37(5):351-5. PubMed ID: 10520160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activity of ketoconazole in mixed cultures of leukocytes and Candida albicans.
    de Brabander M; Aerts F; van Cutsem J; van den Bossche H; Borgers M
    Sabouraudia; 1980 Sep; 18(3):197-210. PubMed ID: 6254187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of action of mechanisms among antimycotic imidazoles.
    Sud IJ; Feingold DS
    Antimicrob Agents Chemother; 1981 Jul; 20(1):71-4. PubMed ID: 6269485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis.
    Vanden Bossche H; Ausma J; Bohets H; Vermuyten K; Willemsens G; Marichal P; Meerpoel L; Odds F; Borgers M
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3272-8. PubMed ID: 15328084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of azole antifungal activity as determined by liquid chromatographic/mass spectrometric monitoring of ergosterol biosynthesis.
    Heimark L; Shipkova P; Greene J; Munayyer H; Yarosh-Tomaine T; DiDomenico B; Hare R; Pramanik BN
    J Mass Spectrom; 2002 Mar; 37(3):265-9. PubMed ID: 11921367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of germ tube formation, filamentation and ergosterol biosynthesis in Candida albicans treated with 6-amino-2-n-pentylthiobenzothiazole.
    Fábry S; Gáborová S; Bujdáková H; Klobusický M; Volleková A; Kuchta T
    Folia Microbiol (Praha); 1999; 44(5):523-6. PubMed ID: 10997135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of ergosterol synthesis by sertaconazole in Candida albicans.
    Agut J; Palacín C; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):718-20. PubMed ID: 1627190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of a new mycotic agent, piritetrate on ergosterol biosynthesis in pathogenic fungi.
    Morita T; Iwata K; Nozawa Y
    J Med Vet Mycol; 1989; 27(1):17-25. PubMed ID: 2666631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of sterol biosynthesis in Candida albicans by imidazole-containing antifungals.
    Marriott MS
    J Gen Microbiol; 1980 Mar; 117(1):253-5. PubMed ID: 6993625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of 14 alpha-desmethyl sterol synthesis in Candida albicans by terconazole, a new triazole antimycotic.
    Isaacson DM; Tolman EL; Tobia AJ; Rosenthale ME; McGuire JL; Vanden Bossche H; Janssen PA
    J Antimicrob Chemother; 1988 Mar; 21(3):333-43. PubMed ID: 3129389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.
    Sanati H; Belanger P; Fratti R; Ghannoum M
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2492-6. PubMed ID: 9371355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.